Pharmaceutical policy at a crossroads: perspectives from Europe and the US

Join us for the official launch event of the Pharmaceutical Policy Lab, which also forms part of LSE Health's 30th anniversary celebrations at which our speakers will explore the evolving landscape of pharmaceutical policy.

Pharmaceutical policy stands at a critical juncture as healthcare systems worldwide grapple with rising costs, emerging technologies, and increasing demands for evidence-based decision-making. New products are often promoted as transformative, yet they also raise complex questions for patients, clinicians, and other stakeholders in healthcare systems. How do we assess value when clinical evidence is limited or uncertain? How can health technology assessment (HTA) systems safeguard access to safe, effective, and cost-effective treatments while supporting innovation that genuinely meets the needs of patients and society?